ObjectivesWe evaluate the diagnostic performance of dried blood microsampling combined with a high-throughput microfluidic nano-immunoassay (NIA) for the identification of anti-SARS-CoV-2 Spike IgG se
Item #3: The samples were collected as part of the program for control and eradication of bovine brucellosis. No inclusion or exclusion criteria were set. Item #4: The recruitment was randomized, espe
Objectives We evaluate the diagnostic performance of dried blood microsampling combined with a high-throughput microfluidic nano-immunoassay (NIA) for the identification of anti-SARS-CoV-2 Spike IgG s